Landau Jeffrey B
- SEC CIK
- 0001918615
No open-market purchases or sales filed in the past year.
Current role at each company
- CTMX CytomX Therapeutics, Inc.Chief Business Officeras of Aug 22, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Landau Jeffrey B as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2024 (view filing) | Aug 20 | 2 days | Landau Jeffrey BChief Business Officer | SSale | −4.18K | $1.23 | −$5.14K | −3.4%119.1K after | |
| Mar 21, 2024 (view filing) | Mar 19 | 2 days | Landau Jeffrey BChief Business Officer | SSale | −6.56K | $2.09 | −$13.7K | −5.6%110.1K after | |
| Dec 22, 2023 (view filing) | Dec 20 | 2 days | Landau Jeffrey BChief Business Officer | SSale | −4.08K | $1.38 | −$5.63K | −4.5%86.6K after | |
| Sep 22, 2023 (view filing) | Sep 22 | Same day | Landau Jeffrey BChief Business Officer | SSale | −4.12K | $1.30 | −$5.35K | −5.1%76.4K after | |
| Mar 20, 2023 (view filing) | Mar 16 | 4 days | Landau Jeffrey BChief Financial Officer | SSale | −1.48K | $1.98 | −$2.92K | −2.1%69.2K after | |
| Jul 21, 2022 (view filing) | Jul 20 | 1 day | Landau Jeffrey BChief Business Officer | SSale | −4.21K | $1.42 | −$5.97K | −12.0%30.7K after |